Anthony Cataldo
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anthony Cataldo
Anthony Cataldo is recorded as CEO at GT Biopharma, Inc. (GTBP). The proxy statement of GT Biopharma, Inc. reports total compensation of $10,494,677 for Anthony Cataldo in fiscal 2021, including a base salary of $479,936. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GT Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Gregory Berk CEO
- Michael Breen CEO, Board Member
- Bruce Wendel Chairman
- Alan L. Urban CFO, Board Member
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Andrew Ritter Board Member
- Charles J. Casamento Board Member
- David C. Mun-Gavin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | GT Biopharma, Inc. (GTBP) | Former Chief Executive Officer | $479,936 | $10,494,677 |
| 2020 | GT Biopharma, Inc. (GTBP) | Former Chief Executive Officer | $323,571 | $428,817 |
Recent activity
No call appearances or filed executive changes recorded yet.